Gut dysbiosis impacts the immune system and promotes prostate cancer
- PMID: 38852888
- PMCID: PMC11249078
- DOI: 10.1016/j.imlet.2024.106883
Gut dysbiosis impacts the immune system and promotes prostate cancer
Abstract
The gut microbiota is a system of microorganisms in the human gastrointestinal (GI) system, consisting of trillions of microorganisms residing in epithelial surfaces of the body. Gut microbiota are exposed to various external and internal factors and form a unique gut-associated immunity maintained through a balancing act among diverse groups of microorganisms. The role of microbiota in dysbiosis of the gut in aiding prostate cancer development has created an urgency for extending research toward comprehension and preventative measures. The gut microbiota varies among persons based on diet, race, genetic background, and geographic location. Bacteriome, mainly, has been linked to GI complications, metabolism, weight gain, and high blood sugar. Studies have shown that manipulating the microbiome (bacteriome, virome, and mycobiome) through the dietary intake of phytochemicals positively influences physical and emotional health, preventing and delaying diseases caused by microbiota. In this review, we discuss the wealth of knowledge about the GI tract and factors associated with dysbiosis-mediated compromised gut immunity. This review also focuses on the relationship of dysbiosis to prostate cancer, the impact of microbial metabolites short-chain fatty acids (SCFAs) on host health, and the phytochemicals improving health while inhibiting prostate cancer.
Keywords: Diet; Microbiota; Obesity; Prostate cancer; Short-chain fatty acids.
Copyright © 2024 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence this work.
Figures


Similar articles
-
Role of the intestinal flora-immunity axis in the pathogenesis of rheumatoid arthritis-mechanisms regulating short-chain fatty acids and Th17/Treg homeostasis.Mol Biol Rep. 2025 Jun 21;52(1):617. doi: 10.1007/s11033-025-10714-w. Mol Biol Rep. 2025. PMID: 40544212 Review.
-
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2. Cochrane Database Syst Rev. 2022. PMID: 36126902 Free PMC article.
-
Gut microbiota dysbiosis -associated obesity and its involvement in cardiovascular diseases and type 2 diabetes. A systematic review.Microvasc Res. 2024 Jan;151:104601. doi: 10.1016/j.mvr.2023.104601. Epub 2023 Sep 9. Microvasc Res. 2024. PMID: 37690507
-
Intestinal inflammation and microbiota modulation impact cochlear function: emerging insights in gut-ear axis.Cell Commun Signal. 2025 Jul 26;23(1):357. doi: 10.1186/s12964-025-02338-1. Cell Commun Signal. 2025. PMID: 40713718 Free PMC article.
-
Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet.Immunol Rev. 2024 Aug;325(1):131-151. doi: 10.1111/imr.13343. Epub 2024 May 8. Immunol Rev. 2024. PMID: 38717158 Free PMC article. Review.
Cited by
-
Prostate and urinary microbiomes in prostate cancer development: focus on Cutibacterium acnes.Front Cell Infect Microbiol. 2025 May 21;15:1562729. doi: 10.3389/fcimb.2025.1562729. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40470262 Free PMC article. Review.
-
Associations between circulating metabolites and pca: a bidirectional two-sample Mendelian randomization study.Discov Oncol. 2025 Jul 18;16(1):1370. doi: 10.1007/s12672-025-03204-9. Discov Oncol. 2025. PMID: 40681942 Free PMC article.
-
Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents.Discov Oncol. 2025 Mar 1;16(1):258. doi: 10.1007/s12672-025-01878-9. Discov Oncol. 2025. PMID: 40024963 Free PMC article. Review.
-
Prostate cancer immunotherapy-based strategies: an updated review emphasizing immune checkpoint inhibitors.Front Immunol. 2025 Jun 18;16:1583363. doi: 10.3389/fimmu.2025.1583363. eCollection 2025. Front Immunol. 2025. PMID: 40607417 Free PMC article. Review.
-
Intestinal Microbiota and Its Effect on Vaccine-Induced Immune Amplification and Tolerance.Vaccines (Basel). 2024 Aug 1;12(8):868. doi: 10.3390/vaccines12080868. Vaccines (Basel). 2024. PMID: 39203994 Free PMC article. Review.
References
-
- Giona S, The Epidemiology of Prostate Cancer, in: Bott SRJ, Ng KL (Eds.) Prostate Cancer, Brisbane (AU), 2021. - PubMed
-
- Paulos CM, Wrzesinski C, Kaiser A, Hinrichs CS, Chieppa M, Cassard L, Palmer DC, Boni A, Muranski P, Yu Z, Gattinoni L, Antony PA, Rosenberg SA, Restifo NP, Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling, J Clin Invest, 117 (2007) 2197–2204. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical